Skin and Subcutaneous Tissue Fungal Infections
Conditions
Brief summary
The purpose of this study was about survey of prevalence of fungal infections among drug users referring to methadone wards of Hospitals in northeast region of Iran
Detailed description
There were two groups with overall members of 1436. Statistically, the investigators have used Likelihood ratio and Exact's Fisher tests.
Interventions
OTHERDirect Examination
It was an observational study and subjects received their routine treatment.
Sponsors
Islamic Azad University of Mashhad
Study design
Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Healthy volunteers
Yes
Inclusion criteria
* Suspected fungal lesions
Exclusion criteria
* non use of local or edible anti-fungal drugs and not taking bath within the last 48 hours of testing
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The Prevalence of Superficial and Cutaneous Fungal Infections Among Drug and Non-Drug Users | up to two months |
Countries
Iran
Participant flow
Participants by arm
| Arm | Count |
|---|---|
| Drug Users Case group that consisted of drug users with fungal infections
Direct Examination: It was an observational study and subjects received their routine treatment. | 718 |
| Non-drug Users Control group that consisted of non drug users with fungal infections
Direct Examination: It was an observational study and subjects received their routine treatment. | 718 |
| Total | 1,436 |
Baseline characteristics
| Characteristic | Drug Users | Non-drug Users | Total |
|---|---|---|---|
| Age, Continuous | 38.3 years | 36.8 years | 37.55 years |
| Region of Enrollment Iran, Islamic Republic of | 718 participants | 718 participants | 1436 participants |
| Sex: Female, Male Female | 116 Participants | 137 Participants | 253 Participants |
| Sex: Female, Male Male | 602 Participants | 581 Participants | 1183 Participants |
Adverse events
| Event type | EG000 affected / at risk | EG001 affected / at risk |
|---|---|---|
| deaths Total, all-cause mortality | — / — | — / — |
| other Total, other adverse events | 0 / 0 | 0 / 0 |
| serious Total, serious adverse events | 0 / 0 | 0 / 0 |
Outcome results
Primary
The Prevalence of Superficial and Cutaneous Fungal Infections Among Drug and Non-Drug Users
Time frame: up to two months
| Arm | Measure | Value (NUMBER) |
|---|---|---|
| Drug Users | The Prevalence of Superficial and Cutaneous Fungal Infections Among Drug and Non-Drug Users | 73 participants |
| Non-drug Users | The Prevalence of Superficial and Cutaneous Fungal Infections Among Drug and Non-Drug Users | 62 participants |